Protocol - Self-reported Exposure to Tobacco Advertising at Point of Sale
This protocol uses a combination of questions from the Wave 1 Adult and Wave 2 Youth Population Assessment of Tobacco and Health (PATH) Survey instruments. Collectively, the questions are used to measure consumer exposure to tobacco-product advertisements, which have been proven to increase the appeal of and demand for tobacco products.
Although questions from both the Youth and Adult Population Assessment of Tobacco and Health (PATH) questionnaires are included in this protocol, the Working Group (WG) believes questions 1-4 may be asked of all respondents. Question 5 should not be asked of youth respondents.
In order to answer question 5, investigators will need to determine whether or not the respondent is not an experimental current user. To do so, the WG is recommending that investigators add the Smoking Status - Adult measure. If the respondent has ever smoked but has not smoked 100 cigarettes in their lifetime and does not smoke every day or some days, then they are eligible to complete question 5.
In addition, the WG recommends that investigators consider clearly defining "tobacco products" by noting whether that definition includes or excludes certain types of related products based on these criteria: products that are intended for human consumption; made or derived from tobacco; typically contain nicotine, but sometimes do not; and are not Food and Drug Administration-approved tobacco-cessation products.
For Question 3, the WG recommends sharing the below list of tobacco products with the respondent to aide in their response.
TOBACCO PRODUCT LIST
1. In the past 30 days, how often did you visit a convenience store, small market, or liquor store?
1[ ]Never [End Questions]
2[ ]Once a month
3[ ]2-3 times per month
4[ ]Once a week
5[ ]2-3 times per week
6[ ]Almost every day
-8[ ]DON’T KNOW
ASK: All respondents.
2. In the past 30 days, when you visited convenience stores, small markets, or liquor stores, how often did you see ads for e-cigarettes?
-8[ ]DON’T KNOW
ASK: Respondents who have visited a store or market.
3. In the past 30 days, when you visited convenience stores, small markets, or liquor stores, how often did you see ads for tobacco products?
-8[ ]DON’T KNOW
ASK: Ask respondents who have visited a store or market.
4. The next questions are about things you may have seen inside or outside shops or stores where people can buy tobacco products. In the past 30 days, have you seen cigarette or other tobacco packages being displayed, including on shelves or on the counter?
-8[ ]DON’T KNOW
ASK: All respondents
5. Since you quit using tobacco, has there been a time when seeing a tobacco product display or other signs that tobacco is sold there, has given you an urge to buy tobacco?
-8[ ]DON’T KNOW
ASK: Former tobacco users who are not experimental current users of tobacco
Personnel and Training Required
|Specialized requirements for biospecimen collection||No|
|Average time of greater than 15 minutes in an unaffected individual||No|
Mode of Administration
Child, Adolescent, Adult
Youth (12-17) and adults (18+)
The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents 12 years old and up are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.
|caDSR Common Data Elements (CDE)||Tobacco Advertisement At Point of Sale Exposure Assessment Scale||4884191||CDE Browser|
Process and Review
Protocol Name from Source
National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA), Population Assessment of Tobacco and Health (PATH) Study, PATH Wave 2 Youth Extended Interview, 2014, Marketing, Advertising, and Promotion, Items R02_YX0182, R02_YX0183, R02_YX0178.
National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA), Population Assessment of Tobacco and Health (PATH) Study, PATH Wave 1 Adult Extended Interview, 2013, Industry, Advertising, and Promotion Section, Items AX0205, AX0212.
National Institutes of Health, U.S. Food and Drug Administration. (2014). Population Assessment of Tobacco and Health (PATH) Study: Attachment 2 English PATH Study Data Collection Instruments: 2a.7 - English Youth: Extended Interview, 2014-06-17. Bethesda, MD: National Institutes of Health. (
National Institutes of Health, U.S. Food and Drug Administration. (2013). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Baseline (Wave 1) Questionnaire. Bethesda, MD: National Institutes of Health.
|Variable Name||Variable ID||Variable Description||dbGaP Mapping|
|PX740501010000||In the past 30 days, how often did you visit more||N/A|
|PX740501030000||In the past 30 days, when you visited more||N/A|
|PX740501020000||In the past 30 days, when you visited more||N/A|
|PX740501040000||The next questions are about things you may more||N/A|
|PX740501050000||Since you quit using tobacco, has there been more||N/A|
Self-reported Exposure to Tobacco Advertising at Point of Sale
June 24, 2015
Instrument used to assess tobacco product advertising exposure at the point of sale, including signs, displays, shelving units, and functional items such as trashcans and ashtrays.
The purpose is to measure consumer exposure to tobacco product advertisements, which have been proven to increase the appeal of and demand for tobacco products.
Tobacco product advertisements, tobacco, product advertisements, advertisements, marketing, cigarette products, branding, Population Assessment of Tobacco and Health Study, PATH, e-cigarettes, retail